Back to Search
Start Over
Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma
- Source :
- Blood Cancer Journal, Vol 14, Iss 1, Pp 1-5 (2024)
- Publication Year :
- 2024
- Publisher :
- Nature Publishing Group, 2024.
- Subjects :
- Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Subjects
Details
- Language :
- English
- ISSN :
- 20445385
- Volume :
- 14
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Blood Cancer Journal
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.91c6bdbb2c0244cbb8d319fe7979abc9
- Document Type :
- article
- Full Text :
- https://doi.org/10.1038/s41408-024-01134-3